- Letter to the editor
- Open Access
Catechin synergistically potentiates mast cell-stabilizing property of caffeine
Allergy, Asthma & Clinical Immunology volume 17, Article number: 1 (2021)
Caffeine and catechin, contained in coffee and tea, are commonly consumed substances worldwide. Studies revealed their health promoting functions, such as anti-oxidant, anti-cancer and anti-bacterial properties. Additionally, studies also revealed their roles in ameliorating the symptoms of allergic disorders, indicating their anti-allergic properties. In the present study, using the differential-interference contrast (DIC) microscopy, we examined the effects of caffeine and catechin on the degranulation from rat peritoneal mast cells. Both caffeine and catechin dose-dependently decreased the numbers of degranulating mast cells. At concentrations equal to or higher than 25 mM, caffeine and catechin markedly suppressed the numbers of degranulating mast cells. In contrast, at relatively lower concentrations, both substances did not significantly affect the numbers of degranulating mast cells. However, surprisingly enough, low concentrations of catechin (1, 2.5 mM) synergistically enhanced the suppressive effect of 10 mM caffeine on mast cell degranulation. These results provided direct evidence for the first time that caffeine and catechin dose-dependently inhibited the process of exocytosis. At relatively lower concentrations, caffeine or catechin alone did not stabilize mast cells. However, low concentrations of catechin synergistically potentiated the mast cell-stabilizing property of caffeine.
To the editor,
Caffeine, a psychoactive alkaloid contained in coffee, and catechin, a polyphenolic flavonoid in tea, are commonly consumed substances worldwide [1, 2]. Previous studies revealed their health promoting functions, including anti-oxidant, anti-cancer and anti-bacterial properties [3, 4]. Additionally, both in humans or experimental animal models, recent studies also revealed their roles in ameliorating the symptoms of allergic disorders, such as bronchial asthma and anaphylaxis [5,6,7,8]. These studies indicated anti-allergic properties of caffeine and catechin, showing their additional pharmacological potency. In our previous studies, by continuously monitoring the process of exocytosis in mast cells, we provided in vitro evidence that anti-allergic drugs, anti-microbial drugs and corticosteroids exert mast cell-stabilizing properties [9,10,11,12,13]. In the present study, to elucidate the mechanisms underlying the anti-allergic properties of caffeine and catechin, we directly examined their effects on the degranulation from rat peritoneal mast cells.
In mast cells isolated from the peritoneal cavity of male Wistar rats (CLEA Japan Inc., Tokyo, Japan), we externally induced exocytosis by compound 48/80 (Sigma-Aldrich; final concentration 10 μg/ml) in the presence or absence of caffeine or catechin. Caffeine anhydrous, purchased from Wako Pure Chem Ind. (Osaka, Japan), was dissolved in the external solution at the final concentrations of 1 mM (194 μg/ml), 5 mM (971 μg/ml), 10 mM (1.94 mg/ml), 25 mM (4.86 mg/ml), 50 mM (9.71 mg/ml) and 100 mM (19.4 mg/ml). d-(+)-catechin hydrate, purchased from Nacalai Tesque Inc. (Kyoto, Japan), was dissolved in the external solution at the final concentrations of 1 mM (290 μg/ml), 2.5 mM (726 μg/ml), 5 mM (1.45 mg/ml), 10 mM (2.90 mg/ml) and 25 mM (7.26 mg/ml). As we described previously [9,10,11,12,13], bright-field images were obtained from randomly chosen 0.1-mm2 fields of view (10 views from each condition). Using the differential-interference contrast (DIC) microscopy, we counted degranulated mast cells and calculated their ratio to all mast cells (Table 1). Degranulated mast cells were defined as cells surrounded by more than 8 granules outside the cell membrane as described previously . Data were analyzed by Microsoft Excel (Microsoft Corporation, Redmond, Wash., USA) and reported as means ± SD. Statistical significance was assessed by two-way ANOVA. A value of p < 0.05 was considered significant.
Mast cells incubated in the external solution alone or relatively lower concentrations of caffeine (1, 5 mM) showed many wrinkles on their cell surface and released secretory granules as a result of exocytosis Fig. 1Ab–d vs. a). However, in mast cells incubated in relatively higher concentrations of caffeine (10, 25, 50, 100 mM), such findings suggestive of exocytosis were partially or completely absent (Fig. 1Ae, f, g, h). Quantitatively, relatively lower concentrations of caffeine (1, 5 mM) did not affect the numbers of degranulating mast cells (Fig. 1B). However, 10 mM caffeine significantly decreased the number of degranulating mast cells (control, 95.4 ± 7.70% vs. 10 mM caffeine, 64.7 ± 23.3%; n = 10, P < 0.05), and concentrations equal to or higher than 25 mM more markedly reduced the numbers of degranulating cells (25 mM caffeine, 21.8 ± 6.96%; 50 mM caffeine, 14.3 ± 3.70%; 100 mM caffeine, 11.1 ± 5.62%; n = 10, P < 0.05; Fig. 1B). Similarly to the findings obtained from caffeine, relatively lower concentrations of catechin (1, 2.5 mM) did not affect the degranulation of mast cells (Fig. 2Ab, c, d) and the numbers of which were almost comparable to those incubated in the external solution alone (Fig. 2B). However, catechin with concentrations equal to or higher than 5 mM partially or entirely halted the process of exocytosis (Fig. 2Ae, f, g) and significantly suppressed the numbers of degranulating mast cells (control, 97.7 ± 2.56% vs. 5 mM catechin, 84.1 ± 6.47%; 10 mM catechin, 77.4 ± 9.18%; n = 10, P < 0.05; Fig. 2B). Twenty-five mM catechin alone showed a marked reduction of the number of degranulating mast cells (35.5 ± 10.7%, n = 10, P < 0.05).
Previous studies indirectly determined the mast cell-stabilizing properties of caffeine or catechin by measuring the amount of chemical mediators released from mast cells [5, 6, 15]. However, besides their exocytotic release of chemical mediators, including histamine, leukotrienes or β-hexosaminidase, mast cells generate various types of inflammatory cytokines or growth factors . In this regard, to accurately define the ability of caffeine or catechin on the stabilization of mast cells, the release of all these substances have to be evaluated. Otherwise, the exocytotic process itself has to be monitored directly in mast cells. In the present study, we carefully observed the whole process of exocytosis under the microscope and actually counted the numbers of degranulating mast cells. Thus, we provided direct evidence for the first time that both caffeine and catechin dose-dependently inhibited the process of exocytosis and thereby exerted mast cell-stabilizing properties.
From our results, despite the lack of statistical significance, relatively lower concentrations of catechin (1, 2.5 mM) tended to decrease the numbers of degranulating mast cells (Fig. 2B). In our recently study, low dose prazosin, an α1-adrenergic receptor blocker, potentiated the ability of adrenaline, the first choice medication for anaphylaxis, to stabilize mast cells . Therefore, expecting the similar additive therapeutic efficacy by low dose substances, we examined the effects of 1 or 2.5 mM catechin on the caffeine-induced inhibition of exocytosis (Fig. 3). Consistent with our results shown in Fig. 1B, 10 mM caffeine significantly but not markedly reduced the number of degranulating mast cells (control, 97.4 ± 1.80% vs. 10 mM caffeine, 46.2 ± 26.1%; n = 10, P < 0.05; Fig. 3B). However, surprisingly enough, in the presence of 1 or 2.5 mM catechin, the exocytotic process of mast cells was almost completely halted (Fig. 3Ac, d vs. b). Regarding the numbers of degranulating mast cells, they were more markedly decreased than those with 10 mM caffeine alone (10 mM caffeine + 1 mM catechin, 22.4 ± 10.9%, n = 34, P < 0.05; 10 mM caffeine + 2.5 mM catechin, 24.9 ± 8.38%, n = 10, P < 0.05; Fig. 3B), showing that the inhibitory effect of caffeine on exocytosis was augmented. These results suggested that lower concentrations of catechin can synergistically potentiate the mast cell-stabilizing property of caffeine.
In mast cells, as we demonstrated in patch-clamp studies , an increase in the intracellular Ca2+ concentration ( [Ca2+]i) is the primary trigger of exocytosis . According to several in vitro studies, caffeine and catechin suppress the elevation of [Ca2+]i either directly or through the activation of adenylate cyclase and the subsequent increase in the intracellular cyclic adenosine monophosphate (cAMP) [5, 6]. Recently, Nishikawa et al. additionally revealed the involvement of reactive oxygen species (ROS) in the effect of catechin on mast cell degranulation . In their study, catechin exerted dual effects depending on the levels of intracellular ROS. When intracellular ROS level was low, catechin paradoxically suppressed the degranulation of mast cells. In the present study, 1 or 2.5 mM catechin alone was not enough to decrease the numbers of degranulating mast cells (Fig. 2B). However, in the presence of 10 mM caffeine, a potent scavenger of ROS , these concentrations of catechin remarkably reduced the numbers of degranulating mast cells (Fig. 3B). From these findings, caffeine-induced decrease in the intracellular ROS level was thought to elicit the ability of low concentrations of catechin to stabilize mast cells, which in turn synergistically potentiated the mast cell-stabilizing property of caffeine itself.
In our series of patch-clamp studies, by detecting the changes in whole-cell membrane capacitance (Cm) in mast cells, we provided electrophysiological evidence that anti-allergic drugs, anti-microbial drugs and corticosteroids inhibit the process of exocytosis, and thus exert mast cell-stabilizing properties [9,10,11,12,13]. Using the same approach in the future, we could more elaborately determine the mast cell-stabilizing property of caffeine or catechin.
In summary, this study provided direct evidence for the first time that caffeine and catechin dose-dependently inhibit the process of exocytosis. At relatively lower concentrations, caffeine or catechin alone did not stabilize mast cells. However, low concentrations of catechin synergistically potentiated the mast cell-stabilizing property of caffeine.
Availability of data and materials
The data used to support the findings of this study are available from the corresponding author upon request.
Yu NY, Bieder A, Raman A, Mileti E, Katayama S, Einarsdottir E, et al. Acute doses of caffeine shift nervous system cell expression profiles toward promotion of neuronal projection growth. Sci Rep. 2017;7:11458.
Narumi K, Sonoda J, Shiotani K, Shigeru M, Shibata M, Kawachi A, et al. Simultaneous detection of green tea catechins and gallic acid in human serum after ingestion of green tea tablets using ion-pair high-performance liquid chromatography with electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;945–946:147–53.
Buldak RJ, Hejmo T, Osowski M, Buldak L, Kukla M, Polaniak R, et al. The impact of coffee and its selected bioactive compounds on the development and progression of colorectal cancer in vivo and in vitro. Molecules. 2018;23:3309.
Cai ZY, Li XM, Liang JP, Xiang LP, Wang KR, Shi YL, et al. Bioavailability of tea catechins and its improvement. Molecules. 2018;23:2346.
Shin HY, Lee CS, Chae HJ, Kim HR, Baek SH, An NH, et al. Inhibitory effect of anaphylactic shock by caffeine in rats. Int J Immunopharmacol. 2000;22:411–8.
Li GZ, Chai OH, Song CH. Inhibitory effects of epigallocatechin gallate on compound 48/80-induced mast cell activation and passive cutaneous anaphylaxis. Exp Mol Med. 2005;37:290–6.
Welsh EJ, Bara A, Barley E, Cates CJ. Caffeine for asthma. Cochrane Database Syst Rev. 2010. https://doi.org/10.1002/14651858.CD001112.pub2CD001112.
Bani D, Giannini L, Ciampa A, Masini E, Suzuki Y, Menegazzi M, et al. Epigallocatechin-3-gallate reduces allergen-induced asthma-like reaction in sensitized guinea pigs. J Pharmacol Exp Ther. 2006;317:1002–11.
Baba A, Tachi M, Maruyama Y, Kazama I. Olopatadine inhibits exocytosis in rat peritoneal mast cells by counteracting membrane surface deformation. Cell Physiol Biochem. 2015;35:386–96.
Baba A, Tachi M, Ejima Y, Endo Y, Toyama H, Matsubara M, et al. Anti-allergic drugs tranilast and ketotifen dose-dependently exert mast cell-stabilizing properties. Cell Physiol Biochem. 2016;38:15–27.
Mori T, Abe N, Saito K, Toyama H, Endo Y, Ejima Y, et al. Hydrocortisone and dexamethasone dose-dependently stabilize mast cells derived from rat peritoneum. Pharmacol Rep. 2016;68:1358–65.
Kazama I, Saito K, Baba A, Mori T, Abe N, Endo Y, et al. Clarithromycin dose-dependently stabilizes rat peritoneal mast cells. Chemotherapy. 2016;61:295–303.
Abe N, Toyama H, Ejima Y, Saito K, Tamada T, Yamauchi M, et al. Alpha 1-adrenergic receptor blockade by prazosin synergistically stabilizes rat peritoneal mast cells. Biomed Res Int. 2020;2020:3214186.
Shimoda T, Liang Z, Suzuki H, Kawana S. Inhibitory effects of antipsychotic and anxiolytic agents on stress-induced degranulation of mouse dermal mast cells. Clin Exp Dermatol. 2010;35:531–6.
Nishikawa H, Kitani S. Tea catechins have dual effect on mast cell degranulation induced by compound 48/80. Int Immunopharmacol. 2008;8:1207–15.
Gruber BL. Mast cells in the pathogenesis of fibrosis. Curr Rheumatol Rep. 2003;5:147–53.
Kuehn HS, Gilfillan AM. G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation. Immunol Lett. 2007;113:59–69.
Ko J, Kim JY, Kim JW, Yoon JS. Anti-oxidative and anti-adipogenic effects of caffeine in an in vitro model of Graves’ orbitopathy. Endocr J. 2020;67:439–47.
We thank Ms. Sanae Matsunaga and Mr. Makoto Shimoyama for their technical support.
This work was supported by MEXT KAKENHI Grant, No. 16K08484, the Salt Science Research Foundation, No. 2028, the Tojuro Iijima Foundation for Food Science and Technology, No. 2019-12 and the Cooperative Study Program (19-305) of National Institute for Physiological Sciences to IK.
Ethics approval and consent to participate
In isolating mast cells from the peritoneal cavity of male Wistar rats, we profoundly anaesthetized the animals with isoflurane and sacrificed them by cervical dislocation. The study was performed in accordance with the guide for the care and use of laboratory animals of Miyagi University, which included ethical considerations. The protocols for the use of the animals were approved by the Animal Care and Use Committee of Miyagi University (Protocol number: 2020-04-01).
Consent for publication
The authors declare that they have no competing interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Yashima, M., Sato, Y. & Kazama, I. Catechin synergistically potentiates mast cell-stabilizing property of caffeine. Allergy Asthma Clin Immunol 17, 1 (2021). https://doi.org/10.1186/s13223-020-00502-5
- Mast cells
- Mast cell
- Stabilizing property